PharmaCyte Biotech
Quarterly Financials
| Values in thousands | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -1,006 | -961 | -2,118 | -1,376 |
EBIT | -1,006 | -961 | -2,118 | -1,376 |
Net Income | -5,081 | -4,393 | 746 | -7,417 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -780 | -1,392 | -786 | -979 |
Cash | 17,738 | 18,603 | 20,165 | 15,406 |
Basic Shares | 10,735 | 10,658 | 9,262 | 6,795 |
Annual Financials
| Values in thousands | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -5,304 | -4,377 | -6,520 | -6,455 |
EBIT | -5,304 | 26,278 | 333 | -10,771 |
Net Income | -19,424 | 30,656 | 333 | -4,315 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,152 | -2,978 | -2,151 | -3,793 |
Cash | 18,603 | 15,172 | 50,179 | 68,039 |
Basic Shares | 8,378 | 7,329 | 9,581 | 19,489 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-07-31 | -$0.54 |
2026-04-30 | -$0.01 |
2026-01-31 | -$0.16 |
2025-10-31 | -$1.24 |